Literature DB >> 25869929

Residual hemifacial spasm after microvascular decompression: prognostic factors with emphasis on preoperative psychological state.

Yichao Jin1, Changyi Zhao, Shanshan Su, Xiaohua Zhang, Yongming Qiu, Jiyao Jiang.   

Abstract

Residual hemifacial spasm (HFS) after microvascular decompression (MVD) is common, and the factors associated with residual HFS are still controversial. In the present study, we analyzed the outcome of 212 patients with hemifacial spasm after a single microvascular decompression and evaluated the prognostic factors involved in residual hemifacial spasm. Based on our study, possible prognostic factors included indentation of the root exit zone (REZ), preoperative illness duration, and preoperative psychological state. We suggest that MVD should be performed as early as possible for it may decrease the rate of residual HFS. Preoperative assessment of psychological state in HFS patients is a timely intervention that should be implemented to minimize the residual HFS.

Entities:  

Mesh:

Year:  2015        PMID: 25869929     DOI: 10.1007/s10143-015-0622-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  25 in total

1.  Delayed effects of the microvascular decompression on hemifacial spasm: a retrospective study of 131 consecutive operated cases.

Authors:  Yoshinobu Goto; Toshio Matsushima; Yoshihiro Natori; Takanori Inamura; Shozo Tobimatsu
Journal:  Neurol Res       Date:  2002-04       Impact factor: 2.448

2.  Prospective study of microvascular decompression in hemifacial spasm.

Authors:  J C Shin; U H Chung; Y C Kim; C I Park
Journal:  Neurosurgery       Date:  1997-04       Impact factor: 4.654

Review 3.  Electrophysiology of the facial nerve in hemifacial spasm: ectopic/ephaptic excitation.

Authors:  V K Nielsen
Journal:  Muscle Nerve       Date:  1985-09       Impact factor: 3.217

4.  Case-control study of anxiety symptoms in hemifacial spasm.

Authors:  Eng-King Tan; Stephanie Fook-Chong; Sau-Ying Lum
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

5.  Abnormal response from the sternocleidomastoid muscle in patients with spasmodic torticollis: observations during microvascular decompression operations.

Authors:  S Saito; A R Møller; P J Jannetta; H D Jho
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Microvascular decompression in hemifacial spasm: intraoperative electrophysiological observations.

Authors:  A R Møller; P J Jannetta
Journal:  Neurosurgery       Date:  1985-05       Impact factor: 4.654

7.  Delayed resolution of residual hemifacial spasm after microvascular decompression operations.

Authors:  M Ishikawa; T Nakanishi; Y Takamiya; J Namiki
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

8.  Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm.

Authors:  A Broocks; A Thiel; D Angerstein; D Dressler
Journal:  Am J Psychiatry       Date:  1998-04       Impact factor: 18.112

9.  Behind the facial twitch: depressive symptoms in hemifacial spasm.

Authors:  Eng-King Tan; Sau-Ying Lum; S Fook-Chong; Ling-Ling Chan; Christopher Gabriel; Leslie Lim
Journal:  Parkinsonism Relat Disord       Date:  2005-06       Impact factor: 4.891

Review 10.  [Neurosurgical treatment of primary hemifacial spasm with microvascular decompression].

Authors:  M Sindou; Y Keravel
Journal:  Neurochirurgie       Date:  2009-03-28       Impact factor: 1.553

View more
  2 in total

1.  Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis.

Authors:  Katherine Holste; Ronald Sahyouni; Zoe Teton; Alvin Y Chan; Dario J Englot; John D Rolston
Journal:  World Neurosurg       Date:  2020-04-16       Impact factor: 2.104

2.  Severe Hemifacial Spasm is a Predictor of Severe Indentation and Facial Palsy after Microdecompression Surgery.

Authors:  Boo Suk Na; Jin Whan Cho; Kwan Park; Soonwook Kwon; Ye Sel Kim; Ji Sun Kim; Jinyoung Youn
Journal:  J Clin Neurol       Date:  2018-04-27       Impact factor: 3.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.